Archive for the ‘Genetic Testing’ Category

Prior studies suggest that referral to genetic counseling and completion of genetic testing vary by race/ethnicity; however, the data are limited.We sought to evaluate patterns of genetic testing and clinical outcomes across race/ethnicity at a hereditary breast and ovarian cancer center.The medical records for all patients undergoing genetic assessment at a hereditary breast and ovarian cancer center were reviewed and stratified by self-reported race/ethnicity (non-Hispanic White, Hispanic, non-Hispanic Black, and Asian).A total of 1666 patients met inclusion criteria (non-Hispanic Whites, 1367; Hispanics, 85, non-Hispanic Blacks, 101; Asians, 113).Demographics, patient characteristics, and referral patterns for patients who underwent genetic testing were analyzed using Kruskal-Wallis tests, chi-square test, or Fishers exact tests, stratifying by self-reported race/ethnicity. Pathogenic mutations and variants of unknown significance (VUS) were reviewed. Outcomes of patients with genetic mutations and personal history of breast and/or gynecologic malignancies were compared.Non-Hispanic Whites were more likely to be referred due to family cancer history compared to all other ethnicities while Non-Hispanic Blacks, Hispanics, and Asians were more likely to be referred due to personal history of cancer (p<0.001). Non-Hispanic Blacks and Hispanics were more likely to have advanced-stage cancer at the time of genetic testing (p<0.02). Rates of mutations did not differ by race/ethnicity when Ashkenazi Jewish patients were excluded (p=0.08). Among patients found to have a BRCA1/2 mutation, Non-Hispanic Whites were more likely to undergo cancer screening and risk-reducing surgery compared with all other ethnicities (p=0.04).Minority patients were more likely to utilize genetic services following a cancer diagnosis and less likely due to family cancer history, suggesting a missed opportunity for mutation detection and cancer prevention in this population. Efforts to eradicate racial/ethnic disparities in early access to genetic testing and guided cancer prevention strategies are essential.

PubMed

See more here:
Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center. - Physician's Weekly

DUBLIN--(BUSINESS WIRE)--The "Global Hereditary Genetic Testing Market: Focus on Product, Sample, Technology, Genetic Testing Type, Application Area, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Hereditary genetic testing has grown significantly since the technology was first commercialized, but it is important to quantify that growth and describe future trends. The genome testing industry is proliferating, and its growth is expected to continue at its torrid pace. However, there are significant challenges that may dampen future growth if not addressed.

Our healthcare experts have found hereditary genetic testing to be one of the most rapidly evolving technologies, and the global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.

The unmet clinical needs for better tools to predict, diagnose, treat, and monitor disease are acting as significant factors driving the growth of the sequencing industry. Other factors driving the growth include the increased understanding of the molecular basis of disease, patient demand, industry investment, and regulations that allow marketing of tests without FDA approval.

Despite rapid advanced sequencing industry growth, there are several key issues that are needed to be addressed to facilitate future growth. The relatively high total costs of delivering sequencing test results compared with other technology platforms, and limited coverage by payers, are the key challenges to the growth of this industry. Whole-genome and exome sequencing remain relatively costly requiring initial equipment investment, specialized workforce requirements, and time-intensive variant interpretation.

Within the research report, the market is segmented on the basis of oncology genetic testing, cardiology genetic testing, neurology genetic testing, product, sample, application area, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Market Dynamics

Drivers

Challenges

Opportunities

Key Questions Answered in this Report:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ry89nq

View post:
Worldwide Hereditary Genetic Testing Industry to 2030 - Rise of Direct-to-Consumer Testing Services Presents Opportunities - ResearchAndMarkets.com -...

Sponsored Content by the Janssen Pharmaceutical Companies of Johnson & Johnson

Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not, as genetic tests can direct healthcare providers to targeted treatment paradigms featuring therapies specific to an individuals genetic makeup.1,2

Various genetic alterations impact how specific tumors can arise or develop, including BRCA1/2, p53, HER2 and the RAS family of genes, among others.3 As researchers continue to study how genetic changes impact cancer development, findings have led to improvements in cancer care including the increased use of targeted therapies and early detection strategies.3

Treating with an inhibitor or a targeted therapy may slow or halt uncontrolled cell growth that may be driven, in part, by a genetically-altered cancer and can provide clinical benefits to patients, said Tracy McGowan, MD, Strategic Area Lead for Medical Affairs at Janssen Biotech, Inc. Analyzing a patients DNA or RNA for actionable genetic alterations can help direct a cancer patients treatment plan, and is intended to provide patients and providers with treatment options that are specific to the unique characteristics of an individuals specific tumor type.

An example of the above is the fibroblast growth factor receptor (FGFR) genetic alteration, which occurs in approximately one in five patients with metastatic urothelial carcinoma (mUC).4,5 FGFR genes, a family of receptor tyrosine kinases, impact tumor cell proliferation, migration and survival in both non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) including mUC.6 This is also true in a variety of other tumor types as well.4

Dr. McGowan is hopeful that, over time, more healthcare providers will recommend genetic testing earlier in the course of bladder cancer to ensure that appropriate treatment options are available for consideration. In the evolving era of precision medicine, it is important to inform patients and their families about the role of genetic testing to help them navigate treatment opportunities. For healthcare providers, talking to patients about the role of genetic testing in their care plan is the beginning of important conversations especially when specific targeted therapies are now available.

References

Visit link:
The Vital Role Genetic Testing Plays in Bladder Cancer Treatments - Cancer Therapy Advisor

Huma Q. Rana, MD, MPH, discusses the rationale for the ProGen trial, which compared the effectiveness of video education versus in-person genetic counseling for men with prostate cancer.

Huma Q. Rana, MD, MPH, anassistant professor of medicine at Harvard Medical School andclinical directorofCancer Genetics and Prevention at Dana-Farber Cancer Institute, discusses the rationale for the ProGen trial, which compared the effectiveness of video education versus in-person genetic counseling for men with prostate cancer.

There are increasing indications for germline genetic testing in prostate cancer, says Rana. Through several clinical studies, the field has recognized that there is a high prevalence of inherited mutations among men with advanced prostate cancers, and this could have significant implications on treatment. Men with advanced prostate cancer, particularly those with underlying mutations in genes such asBRCA2, are known to have poor outcomes, says Rana. Therefore, it is important to identify these men and make matched targeted therapy available to them and their oncologists.

In recognizing that prostate cancer is a very common disease and that traditional germline genetic testing would be very difficult to implementpotentially overwhelming already strained systems for genetic testinga randomized controlled trialwas conducted. In the trial, investigators compared the effectiveness of a short videothat focused on the educational components of a genetic counseling visit with in-person genetic counseling for men with potentially lethal prostate cancers, concludes Rana.

View original post here:
Dr. Rana on the Rationale for Video Genetic Counseling in Prostate Cancer - OncLive

Global Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Report 2020 presents critical information and factual data about the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market, providing an overall statistical study of this market on the basis of market drivers, market limitations, and its future prospects. The widespread Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market opportunities and trends are also taken into consideration in Predictive Genetic Testing And Consumer (Wellness) Genomics Industry industry. with growth trends, various stakeholders like investors, traders, suppliers, SWOT analysis Opportunities and Threat to the organization and others.

The Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market report comprises of the key trends which influence the industry growth with respect to the regional terrain and competitive arena. The study highlights the opportunities that will support the industry expansion in existing and untapped markets along with the challenges the business sphere will face. Besides this, the report also offers an intricate analysis of case studies including those of COVID-19 pandemic, with the aim to provide a clear picture of this industry vertical to all shareholders.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/27761

Pivotal pointers from COVID-19 impact assessment:

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/27761

Analysis of the regional terrain:

Highlights of the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market report:

Key Coverage of report:

Impact of the latest technological innovations on the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market

Key growth strategies adopted by the prominent market players to address the challenges and restraints put forward by the COVID-19 pandemic

Historical and current trends likely to affect the overall market dynamics of the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market

Growth assessment of the various market segments over the forecast timeline

Regional and global presence of major market players in the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market

Table of Content:

1 Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Predictive Genetic Testing And Consumer (Wellness) Genomics Industry industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Size, 2015 - 2020

2.1.2 Global Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Size by Type, 2015 - 2020

2.1.3 Global Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Size by Application, 2015 - 2020

2.1.4 Global Predictive Genetic Testing And Consumer (Wellness) Genomics Industry market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Predictive Genetic Testing And Consumer (Wellness) Genomics Industry Industry Development

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/27761

Read the original post:
Predictive Genetic Testing And Consumer (Wellness) Genomics Industry Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and...

New Jersey, United States,- The research report on Preimplantation Genetic Testing market comprises of insights in terms of pivotal parameters such as production as well as the consumption patterns alongside revenue estimations for the projected timeframe. Speaking of production aspects, the study offers an in-depth analysis regarding the manufacturing processes along with the gross revenue amassed by the leading producers operating in this business arena. The unit cost deployed by these producers in various regions during the estimated timeframe is also mentioned in the report.

Significant information pertaining to the product volume and consumption value is enlisted in the document. Additionally, the report contains details regarding the consumption graphs, Individual sale prices, and import & export activities. Additional information concerning the production and consumption patterns are presented in the report.

In market segmentation by manufacturers, the report covers the following companies-

Exploring the growth rate over a period

Business owners looking to scale up their business can refer this report that contains data regarding the rise in sales within a given consumer base for the forecast period, 2020 to 2027. Product owners can use this information along with the driving factors such as demographics and revenue generated from other products discussed in the report to get a better analysis of their products and services. Besides, the research analysts have compared the market growth rate with product sales to enable business owners to determine the success or failure of a specific product or service.

By Type

By Application

Regions Covered in the Global Preimplantation Genetic Testing Market:

The Middle East and Africa (GCC Countries and Egypt)

North America (the United States, Mexico, and Canada)

South America (Brazil etc.)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Highlights of the Report:

Accurate market size and CAGR forecasts for the period 2020-2026

Identification and in-depth assessment of growth opportunities in key segments and regions

Detailed company profiling of top players of the global Preimplantation Genetic Testing market

Exhaustive research on innovation and other trends of the global Preimplantation Genetic Testing market

Reliable industry value chain and supply chain analysis

Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

The scope of the Report:

The report offers a complete company profiling of leading players competing in the global Preimplantation Genetic Testing marketwith a high focus on the share, gross margin, net profit, sales, product portfolio, new applications, recent developments, and several other factors. It also throws light on the vendor landscape to help players become aware of future competitive changes in the global Preimplantation Genetic Testing market.

Reasons to Buy the Report:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

See more here:
Preimplantation Genetic Testing Market Market Dynamics, Opportunities and Risks 2027 - Owned

Editors note: Jeopardy! host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy combination for their pancreatic cancer. The Pancreatic Cancer Action Network (PanCAN) strongly recommends clinical trials for all pancreatic cancer patients. Learn more below about immunotherapy and other types of clinical trials aiming to improve pancreatic cancer patient outcomes.

Pancreatic cancer patients who participate in clinical research have better outcomes. And every treatment available today was approved through a clinical trial. PanCAN therefore strongly recommends clinical trials at diagnosis and during every treatment decision.

Contact PanCANs Patient Services for questions about pancreatic cancer treatment and clinical trials, including a personalized clinical trials search.

There are approximately 170 pancreatic cancer clinical trials currently enrolling patients across the U.S. (Please note that some trials have been affected by the coronavirus disease pandemic and may have been modified or put on hold.)

The goals of pancreatic cancer clinical trials is to determine whether experimental treatment options are safe for patients and more effective than the current standard of care.

Clinical trials may test an experimental drug, treatment approach or combination. They may include standard drugs or approaches (e.g., chemotherapy, surgery or radiation therapy). The experimental approach is compared to the best available standard of care.

Immunotherapy has revolutionized the treatment of some solid tumors, but the strategy has shown limited effectiveness in most pancreatic cancer patients to date.

Immunotherapy involves activating and training the patients immune system to recognize and attack cancer cells. Turning on the patients immune system is often not enough, however cancer cells and their surrounding microenvironment can often block an immune attack. So, many immunotherapeutic approaches include stopping this evasion in addition to activating the immune system.

One type of immunotherapy that has been approved to treat some pancreatic cancer patients is called Keytruda (pembrolizumab). Keytruda has been shown to be effective in patients with pancreatic cancer and other solid tumors with certain molecular features.

Basing treatment on a patients biology is known as precision medicine. PanCAN strongly recommends all pancreatic cancer patients get tested both biomarker tumor tissue testing and genetic testing for inherited mutations to determine whether certain treatments may be especially effective for them. Both types of test are available through PanCANs Know Your Tumor precision medicine service.

Other types of immunotherapy are being tested in patients regardless of their biology.

The experimental treatment combination that Trebek and Reid have mentioned involves several experimental immunotherapy drugs in combination with standard treatments. Clinical trials are underway to determine whether this treatment combination is safe and effective in patients with pancreatic cancer.

We are grateful to both Trebek and Reid for bringing awareness to the disease and to the need for more and more effective treatment options for patients. More data will be necessary to determine whether the experimental treatment theyre receiving is better than standard of care options.

Read more from the original source:
Things to Know About Immunotherapy Clinical Trials Pancreatic Cancer Action Network - Pancreatic Cancer News & Stories

Global Direct-to-consumer Genetic Testing Market: Trends Estimates High Demand by 2027

The Direct-to-consumer Genetic Testing Market 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Direct-to-consumer Genetic Testing Industry Report is an in-depth study analyzing the current state of the Direct-to-consumer Genetic Testing Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Direct-to-consumer Genetic Testing Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.

The last section of the report focuses on the extensive competitive landscape, which includes some of the details of prominent players of the Direct-to-consumer Genetic Testing market. It also covers the strategies adopted by these players for retaining their dominance in the market. These strategies may involve mergers and acquisitions, partnerships, collaborations, investment in research and developments (R&Ds), new product launches, and business expansion. It helps to keep an eye on recent development in the market including product innovation and new product approvals by the government authorities.

The final report will add the analysis of the Impact of Covid-19 in this report Direct-to-consumer Genetic Testing industry.

Major Companies Covered in Research Report: Myriad Genetics, Inc., 23andMe, Inc., Invitae, Ambry Genetics, Laboratory Corporation of America, African Ancestry, MyHeritage, AncestrybyDNA, Counsyl, Inc., Pathway Genomics, DNA Services of America, Positive Bioscience Ltd., Quest Diagnostics, Sonora Quest Laboratories, Gene by Gene, and Mapmygenome.

Get a Free Sample [emailprotected] https://www.reportsandmarkets.com/sample-request/global-direct-to-consumer-genetic-testing-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=primefeed&utm_medium=33

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Direct-to-consumer Genetic Testing Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and development plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Global Direct-to-consumer Genetic Testing Market Research Report 2020 carries in-depth case studies on the various countries which are involved in the Direct-to-consumer Genetic Testing market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Direct-to-consumer Genetic Testing market report answer pertaining to the regional reach of the industry

The report claims to split the regional scope of the Direct-to-consumer Genetic Testing market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present How does the sales scenario look for the future

Considering the present scenario, how much revenue will each region attain by the end of the forecast period

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

A short overview of the Direct-to-consumer Genetic Testing market scope:

Global market remuneration

Overall projected growth rate

Industry trends

Competitive scope

Product range

Application landscape

Supplier analysis

Marketing channel trends Now and later

Sales channel evaluation

Market Competition Trend

Market Concentration Rate

Reasons for Read this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

Chapter 1:Direct-to-consumer Genetic Testing Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3:Direct-to-consumer Genetic Testing Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Direct-to-consumer Genetic Testing Market Effect Factors Analysis

Chapter 12: GlobalDirect-to-consumer Genetic Testing Market Forecast to 2027

To Know More of This Report @ https://www.reportsandmarkets.com/enquiry/global-direct-to-consumer-genetic-testing-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?utm_source=primefeed&utm_medium=33

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Read the original here:
Research on Direct-to-consumer Genetic Testing Market (impact of COVID-19) with Top Players: Myriad Genetics, Inc., 23andMe, Inc., Invitae, Ambry...

DataIntelo, one of the worlds prominent market research firms has announced a novel report on Global Point-of-Care Genetic Testing Market. The report contains vital insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Point-of-Care Genetic Testing market to figure out and study the market needs, market size, and competition. The report incorporates data regarding the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players during the forecast period of 2020-2027.

Get A Free Sample Report @ https://dataintelo.com/request-sample/?reportId=46729

Impact of COVID-19 on Point-of-Care Genetic Testing Market

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Point-of-Care Genetic Testing market and what the future holds for it. It provides an analysis of the effects of the pandemic on the global economy. The outbreak has directly disturbed the demand and supply chain. The report also analyzes the financial impact on firms and financial markets. DataIntelo has gathered insights from several delegates of the industry and got involved in the primary and secondary research to provide the clients with data and strategies to combat the market challenges during and after COVID-19 pandemic.

Benefits of buying the report:

Industry experts and research analysts have worked extensively to prepare the research report which will help you to give that extra edge in the competitive market. The market research report can be customized according to you to your needs. This means that DataIntelo can cover a particular product, application, or can provide a detailed analysis in the report. You can also purchase a separate report for a specific region.

You can buy the complete report @ https://dataintelo.com/checkout/?reportId=46729

Some of the major companies that are covered in this report:

Roche (Switzerland)Thermo Fisher Scientific (US)Cepheid (US)IQuum (US)Biocartis (Switzerland)Idaho Technologies (US)

*Note: Additional companies can be included on request

The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:

By Application:

Diagnostic LabsBio-Pharmaceutical IndustryAcademic InstitutionsOther

By Type:

Product Type IProduct Type IIProduct Type III

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is included in the report is the regional analysis to assess the global presence of the Point-of-Care Genetic Testing market. You can also opt for a yearly subscription of all the updates on the Point-of-Care Genetic Testing market.

Request a sample before buying this report @ https://dataintelo.com/request-sample/?reportId=46729

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Point-of-Care Genetic Testing Market Overview

Point-of-Care Genetic Testing Supply Chain Analysis

Point-of-Care Genetic Testing Pricing Analysis

Global Point-of-Care Genetic Testing Market Analysis and Forecast by Type

Global Point-of-Care Genetic Testing Market Analysis and Forecast by Application

Global Point-of-Care Genetic Testing Market Analysis and Forecast by Sales Channel

Global Point-of-Care Genetic Testing Market Analysis and Forecast by Region

North America Point-of-Care Genetic Testing Market Analysis and Forecast

Latin America Point-of-Care Genetic Testing Market Analysis and Forecast

Europe Point-of-Care Genetic Testing Market Analysis and Forecast

Asia Pacific Point-of-Care Genetic Testing Market Analysis and Forecast

Asia Pacific Point-of-Care Genetic Testing Market Size and Volume Forecast by Application

Middle East & Africa Point-of-Care Genetic Testing Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, feel free to reach us! @ https://dataintelo.com/enquiry-before-buying/?reportId=46729

About DataIntelo:

DataIntelo has a vast experience in making customized market research reports in various industry verticals. Our motto is to provide complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo.com

Natalia is Business Writer Carrying A Vast Experience Over a Decade , She Helps TechinFeed Blog with her Expertise Business Articles

See more here:
Point-of-Care Genetic Testing Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast...

In this report, the global At-home Genetic Testing market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The At-home Genetic Testing market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the At-home Genetic Testing market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2601844&source=atm

The key players covered in this study23andMeMyHeritageLabCorpMyriad GeneticsAncestry.comQuest DiagnosticsGene By GeneDNA Diagnostics CenterInvitaeIntelliGeneticsAmbry GeneticsLiving DNAEasyDNAPathway GenomicsCentrillion TechnologyXcodeColor GenomicsAnglia DNA ServicesAfrican AncestryCanadian DNA ServicesDNA Family CheckAlpha BiolaboratoriesTest Me DNA23 MofangGenetic HealthDNA Services of AmericaShuwen Health SciencesMapmygenomeFull Genomes

Market segment by Type, the product can be split intoDiagnostic ScreeningPGDRelationship testingMarket segment by Application, split intoOnlineOffline

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global At-home Genetic Testing status, future forecast, growth opportunity, key market and key players.To present the At-home Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of At-home Genetic Testing are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2601844&source=atm

The study objectives of At-home Genetic Testing Market Report are:

To analyze and research the At-home Genetic Testing market status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the At-home Genetic Testing manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions At-home Genetic Testing market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the keyword market.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2601844&licType=S&source=atm

Read the original:
How Innovation is Changing the At-home Genetic Testing Market - Market Research Correspondent

DataIntelo offers a detailed report on Global Breast Cancer Predictive Genetic Testing Market. The report is a comprehensive research study that provides the scope of Breast Cancer Predictive Genetic Testing market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements of the clients and assisting them to make right decision about their business investment plans and strategies.

The Breast Cancer Predictive Genetic Testing market report also covers an overview of the segments and sub-segmentations including the product types, applications, companies and regions. This report further includes the impact of COVID-19 on the market and explains dynamics of the market, future business impact, competition landscape of the companies, and the flow of the global supply and consumption. The report provides an in-depth analysis of the overall market structure of Breast Cancer Predictive Genetic Testing and assesses the possible changes in the current as well as future competitive scenarios of the Breast Cancer Predictive Genetic Testing market.

Request A Free Sample Report @ https://dataintelo.com/request-sample/?reportId=118830

The published report consists of a robust research methodology by relying on primary source including interviews of the company executives & representatives and accessing official documents, websites, and press release of the companies. DataIntelo is known for its data accuracy and granular market reports.

The report is prepared with a group of graphical representations, tables, and figures which displays a clear picture of the developments of the products and its market performance over the last few years. With this precise report, it can be easily understood the growth potential, revenue growth, product range, and pricing factors related to the Breast Cancer Predictive Genetic Testing market. The report also covers the recent agreements including merger & acquisition, partnership or joint venture and latest developments of the manufacturers to sustain in the global competition of the Breast Cancer Predictive Genetic Testing market.

Key companies that are covered in this report:

RocheThermo Fisher ScientificPerkinElmerQuest DiagnosticsMyriad GeneticsIverson GeneticsCancer GeneticsOncoCyte CorporationNeoGenomicsInvitae

*Note: Additional companies can be included on request

The report covers a detailed performance of some of the key players and analysis of major players in the industry, segments, application, and regions. Moreover, the report also considers the governments policies in different regions which illustrates the key opportunities as well as challenges of the market in each region.

By Application:

HospitalsClinicsOther

By Type:

High Penetrant GenesIntermediate Penetrant GenesLow Penetrant Genes

As per the report, the Breast Cancer Predictive Genetic Testing market is projected to reach a value of USDXX by the end of 2027 and grow at a CAGR of XX% through the forecast period (2020-2027). The report describes the current market trend of the Breast Cancer Predictive Genetic Testing in regions, covering North America, Latin America, Europe, Asia Pacific, and Middle East & Africa by focusing the market performance by the key countries in the respective regions. According to the need of the clients, this report can be customized and available in a separate report for the specific region.

You can also go for a yearly subscription of all the updates on Breast Cancer Predictive Genetic Testing market.

You can buy the complete report @ https://dataintelo.com/checkout/?reportId=118830

The following is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Breast Cancer Predictive Genetic Testing Market Overview

Breast Cancer Predictive Genetic Testing Supply Chain Analysis

Breast Cancer Predictive Genetic Testing Pricing Analysis

Global Breast Cancer Predictive Genetic Testing Market Analysis and Forecast by Type

Global Breast Cancer Predictive Genetic Testing Market Analysis and Forecast by Application

Global Breast Cancer Predictive Genetic Testing Market Analysis and Forecast by Sales Channel

Global Breast Cancer Predictive Genetic Testing Market Analysis and Forecast by Region

North America Breast Cancer Predictive Genetic Testing Market Analysis and Forecast

Latin America Breast Cancer Predictive Genetic Testing Market Analysis and Forecast

Europe Breast Cancer Predictive Genetic Testing Market Analysis and Forecast

Asia Pacific Breast Cancer Predictive Genetic Testing Market Analysis and Forecast

Middle East & Africa Breast Cancer Predictive Genetic Testing Market Analysis and Forecast

Competition Landscape

Why you should buy this report?

This report offers a concise analysis of the Breast Cancer Predictive Genetic Testing market for the last 5 years with historical data & more accurate prediction for upcoming 6 years on the basis of statistical information.

This report helps you to understand the market components by offering a cohesive framework of the key players and their competition dynamics as well as strategies.

The report is a complete guideline for the clients to arrive an informed business decision since it consists of a detailed information for better understandings of the current & future market situation.

The report also answers some of the key questions given below:

Which end-user is likely to play a crucial role in the development of the Breast Cancer Predictive Genetic Testing market?

Which regional market is expected to dominate the Breast Cancer Predictive Genetic Testing market in 2020-2027?

How is consumer consumption behavior impacting the business operations of market players in the current scenario of the Breast Cancer Predictive Genetic Testing market?

If you have any questions on this report, please reach out to us @ https://dataintelo.com/enquiry-before-buying/?reportId=118830

About DataIntelo:

We possess expertise in a variety of business intelligence domains. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo.com

Link:
Impact Of Covid-19 On Breast Cancer Predictive Genetic Testing Market Is To Witness Significant Growth Between 2020-2027 With Leading Players Roche,...

The Genetic Testing market research report 2020 provides an in-depth analysis of significant market dynamics. The report comprehensively emphasizes on drivers, restraints, trends and opportunities prevailing in the global and regional market. The report studies all key market information including revenue, market share, segmentation breakdown. The Genetic Testing market report offers an analysis of the key players with their product offerings, business strategies, and geographical presence.

Global Genetic Testing market size is estimated to grow at a CAGR of over 12% with Revenue USD 4.86billion during the forecast period 2020-2024.

Get a Sample Copy of the Report https://www.industryresearch.co/enquiry/request-sample/14966951

About Genetic Testing Market:

Genetic Testing Market analysis considers sales from both equipment and consumable products. Our study also finds the sales of genetic testing in Asia, Europe, North America, and ROW. In 2019, the equipment segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing workload for performing high-throughput tests in clinical diagnostic facilities will play a significant role in the equipment segment to maintain its market position. Also, our global genetic testing market report looks at factors such as rising prevalence of genetic diseases and disorders, rising approval of advanced genetic testing products, and increasing affordability due to reduction in cost of genetic testing. However, varying regulations on genetic testing and research globally, issues related to product recalls, and lack of trained genetic professionals may hamper the growth of the genetic testing industry over the forecast period.

Some Key Players of Genetic Testing Market Are:

To Understand How Covid-19 Impact is Covered in This Report https://www.industryresearch.co/enquiry/request-covid19/14966951

Market Dynamics of Genetic Testing Market:

Driver: Rising Approval Of Advanced Genetic Testing Products

Trends: Growing Adoption Of Pharmacogenetic Testing In Reducing Adverse Drug Events

Challenges: Lack Of Trained Genetic Professionals

Rising approval of advanced genetic testing products

Commercial applications of genetic screening in human health management and the advent of whole genome sequencing have allowed vendors to offer a variety of innovative products in the global genetic testing market. The use of advanced technologies such as pharmacogenomics and companion diagnostics has helped vendors in assuring the safety of their products. Furthermore, the deployment of rapid and simplified technologies in genetic testing offers several benefits including the reduction in turnaround time, optimum resource use, and accuracy in genetic diagnosis. Thus, the rising approval of advanced genetic testing products will lead to the expansion of the global genetic testing market at a CAGR of over 12% during the forecast period.

Growing adoption of pharmacogenetic testing in reducing adverse drug events

The growing approval of new drug molecules and the rising demand for targeted therapies and personalized medicines have increased the adoption of pharmacogenomic testing by pharmaceutical companies. Pharmacogenomic testing combines the principles of pharmacology and genomics to study the response of an individual to any specific drug. The study of drug-specific responses allows pharmaceutical companies to prevent adverse drug incidence and ensure drug safety and performance during pre and post commercial stages. This development is expected to have a positive impact on the overall market growth.

Genetic Testing Market Segmentation Analysis:

By Type:

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/14966951

Genetic Testing Market Report Highlights:

Genetic Testing Market Segment by Regions:

Purchase this Report (Price 2500 USD for single user license) https://www.industryresearch.co/purchase/14966951

Some Points from Genetic Testing Market Report TOC:

PART01:EXECUTIVESUMMARY

PART02:SCOPEOFTHEREPORT

PART03:MARKETLANDSCAPE

PART04:MARKETSIZING

PART05:FIVEFORCESANALYSIS

PART06:MARKETSEGMENTATIONBYTECHNOLOGY

PART07:MARKETSEGMENTATIONBYFURNACETYPE

PART08:CUSTOMERLANDSCAPE

PART09:GEOGRAPHICLANDSCAPE

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

For Detailed TOC Click Here

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Crop Growth Regulators Market 2020 Global Business Growth, Industry Size, Share, Revenue, Trends, Global Market Demand Penetration and Forecast to 2025

Millimeter Wave Scanner Market 2020| Worldwide Overview by Industry Size, Market Share, Future Trends, Growth Factors and Leading Players Research Report Analysis till 2025

Titanium Diboride Powders Market 2020 2026 | Global Industry Manufacturing Size, Share, Business Insights, Development Status, Key Challenges and Forecast Analysis Industry Research.co

Impact/Shock Recorders Market 2020 Current Industry Trends, Global Key Barriers, New Opportunities, Key Players Overview, Evolving Technology by 2024 by Industry Research.co

Graphite Block Market Size Forecast Analysis by Global Opportunities 2020: Development Status, Organization Share, Market Components, and Regional Outlook till 2026

Biliary Stent Market Business Strategy, Development Plans 2020: Trends Analysis, Industry Outlook, Global Opportunities, Market Share and Size, Present Scenario of Manufacturers Forecast to 2026

Original post:
Genetic Testing Market Drivers, Growth Rate Analysis 2020 Global Industry Analysis, Key Venders, Global Trends, Size, Share and Profits Forecast to...

Global Prenatal and New-born Genetic Testing Market Report briefly splits the worldwide Prenatal and New-born Genetic Testing market based on product type, various applications, and geographical regions. The data portrayed in the report is collected from various global industrys that help us to calculate the growth of the segments in the forecast period. Apart from this, the report demonstrates the competitive set-up in the global Prenatal and New-born Genetic Testing market.

Get a Sample Copy of report https://www.marketreportsworld.com/enquiry/request-sample/15902182

Prenatal and New-born Genetic Testing Market provides sizing and growth opportunities for the period 2020-2025. Provides comprehensive insights on the latest industry trends, forecast, and growth drivers in the market. Report Includes a detailed analysis of growth drivers, challenges, and investment opportunities. Delivers a complete overview of segments and the regional outlook of the market. Prenatal and New-born Genetic Testing Market Offers an exhaustive summary of the vendor landscape, competitive analysis, and key strategies to gain competitive advantage.

To Understand How COVID-19 Impact is Covered in This Report. Get Sample copy of the report at : https://www.marketreportsworld.com/enquiry/request-covid19/15902182

List Of Best KEY PLAYERS in Prenatal and New-born Genetic Testing Market Report are:-

About Prenatal and New-born Genetic Testing Market:

Market Analysis and Insights: Global Prenatal and New-born Genetic Testing MarketThe global Prenatal and New-born Genetic Testing market size is projected to reach US$ 3920 million by 2026, from US$ 3647.2 million in 2020, at a CAGR of 6.9%% during 2021-2026.Global Prenatal and New-born Genetic Testing

Prenatal and New-born Genetic Testing Market By Type:

Prenatal and New-born Genetic Testing Market By Application:

Inquire more and share questions if any before the purchase on this report at https://www.marketreportsworld.com/enquiry/pre-order-enquiry/15902182

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Prenatal and New-born Genetic Testing in these regions, from 2015 to 2025, covering

The study objectives of this report are:

Key Stakeholders

Purchase this report (Price 3900 USD for a single-user license) https://www.marketreportsworld.com/purchase/15902182

Major Points from Table of Contents:

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered1.4 Market Analysis by Type1.4.1 Global Prenatal and New-born Genetic TestingMarket Size Growth Rate by Type (2014-2025)1.4.2 Major-Type1.4.3 Independent-Type1.4.4 Administrator-Type1.5 Market by Application1.5.1 Global Prenatal and New-born Genetic TestingMarket Share by Application (2014-2025)1.5.2 Commercial1.5.3 Commonweal1.5.4 Other1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends2.1 Prenatal and New-born Genetic TestingMarket Size2.2 Prenatal and New-born Genetic TestingGrowth Trends by Regions2.2.1 Prenatal and New-born Genetic TestingMarket Size by Regions (2014-2025)2.2.2 Prenatal and New-born Genetic TestingMarket Share by Regions (2014-2020)2.3 Industry Trends2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Opportunities

3 Market Share by Key Players3.1 Prenatal and New-born Genetic TestingMarket Size by Manufacturers3.1.1 Global Prenatal and New-born Genetic TestingRevenue by Manufacturers (2014-2020)3.1.2 Global Prenatal and New-born Genetic TestingRevenue Market Share by Manufacturers (2014-2020)3.1.3 Global Prenatal and New-born Genetic TestingMarket Concentration Ratio (CR5 and HHI)3.2 Prenatal and New-born Genetic TestingKey Players Head office and Area Served3.3 Key Players Prenatal and New-born Genetic TestingProduct/Solution/Service3.4 Date ofEnterinto Prenatal and New-born Genetic TestingMarket3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application4.1 Global Prenatal and New-born Genetic TestingMarket Size by Type (2014-2020)4.2 Global Prenatal and New-born Genetic TestingMarket Size by Application (2014-2020)

(5, 6, 7, 8, 9, 10, 11) United States, Europe,China,Japan,Southeast Asia,India,Central & South AmericaPrenatal and New-born Genetic TestingMarket Size (2014-2020)Key PlayersPrenatal and New-born Genetic TestingMarket Size by TypePrenatal and New-born Genetic TestingMarket Size by Application

12 International Players ProfilesCompany DetailsCompany Description and Business OverviewPrenatal and New-born Genetic TestingIntroductionRevenue in Prenatal and New-born Genetic TestingBusiness (2014-2020)Recent Development

13 Market Forecast 2020-202513.1 Market Size Forecast by Regions13.2 United States13.3 Europe13.4 China13.5 Japan13.6 Southeast Asia13.7 India13.8 Central & South America13.9 Market Size Forecast by Product (2020-2025)13.10 Market Size Forecast by Application (2020-2025)

14 Analysts Viewpoints/Conclusions

15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.1.1 Research Programs/Design15.1.1.2 Market Size Estimation12.1.1.3 Market Breakdown and Data Triangulation15.1.2 Data Source15.1.2.1 Secondary Sources15.1.2.2 Primary Sources15.2 Disclaimer15.3 Author Details

Continued.

About Us:

Market Reports Worldis the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided todays businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

CONTACT US

Name: Ajay More

Email:[emailprotected]

Phone:US +1 424 253 0807 /UK +44 203 239 8187

Other Reports Here:

Neuroprosthetic System Market Industry Share, Size:2020 Market Research with Growth, Manufacturers, Segments and 2024 Forecasts Research

Folic Acid Market 2020 Size,Share Global Growth Analysis, Trends, Industry Analysis, Key Players and Forecast to 2026

Lithium Silicate Market Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Updates by Forecast to 2026

Naltrexone HCL Market 2020 Size,Share Global Future Trend, Segmentation, Business Growth, Top Key Players Analysis Industry, Opportunities and Forecast to 2026

Magnetic Separators For Waste And Recycling Market 2020 Size,Share Global Forthcoming Developments, Industry Updates, Leading Players,Future Growth, Business Prospects and Future Investments by Forecast to 2025

Yeast and Yeast Extract Market 2020 Size,Share Global Competition Strategies, Statistics, Industry Trends, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2024

Read more from the original source:
Prenatal and New-born Genetic Testing Market 2020 Size with Top Manufactures are Agilent Technologies, Inc.,Bio-Rad Laboratories, Inc.,Natera,...

New York, July 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hereditary Genetic Testing Market: Focus on Product, Sample, Technology, Genetic Testing Type, Application Area, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" - https://www.reportlinker.com/p05930381/?utm_source=GNW

Product Type:Kits, Consumables, and Services Sample Type: Tumor Tissue, Blood, Saliva, Bone Marrow Technology: Next Generation Sequencing, Polymerase Chain Reaction,Immunohistochemistry, In-situ Hybridization, Microarray Techniques Oncology Genetic Testing: Breast, Colorectal,Prostate, Lung, Melanoma Cardiology Genetic Testing: Cardiomyopathy,Aortopathy, Arrythmia Neurology Genetic Testing: Epilepsy, Neurodegenerative Disorders, Neuromuscular Disorders Other Genetic Testing: Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing Application Area: Academia and Research Centers, Clinical Diagnostics, Drug Discovery, Monitoring and Screening

Regional Segmentation North America U.S., Canada Europe Germany, France, Italy, U.K., Spain, Russia, Netherlands Asia-Pacific Japan, China, India, Australia, Singapore Latin America Brazil, Mexico Rest-of-the-World Kingdom of Saudi Arabia (K.S.A.), U.A.E., Palestine, Algeria

Cross Segmentation North America Genetic Testing Type (Oncology Genetic Testing, Cardiology Genetic Testing, Neurology Genetic Testing, Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing Europe Genetic Testing Type (Oncology Genetic Testing, Cardiology Genetic Testing, Neurology Genetic Testing, Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing Asia-Pacific - Genetic Testing Type (Oncology Genetic Testing, Cardiology Genetic Testing, Neurology Genetic Testing, Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing Latin America Genetic Testing Type (Oncology Genetic Testing, Cardiology Genetic Testing, Neurology Genetic Testing, Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing Rest-of-the-World Genetic Testing Type (Oncology Genetic Testing, Cardiology Genetic Testing, Neurology Genetic Testing, Newborn Screening, NIPT, Rare Disease Testing, Direct to Consumer Testing

Growth Drivers Rising Prevalence of Genetic Disorders Increasing Prevalence of Various Types of Cancer, Globally Increasing Research Funding in the Field of Genomics

Market Challenges Expensive Sequencing Procedures and Their Applications in Medical Treatments High Capital Requirement Hampering the Expansion of Global Reach Stringent Regulatory Standards

Market Opportunities Technological Advancements for Exome Sequencing Rise of Direct-to-Consumer (DTC) Testing Services Massive Scope for Adoption of NGS-Based in Emerging Nations

Key Companies ProfiledAgilent Technologies, Inc., Ambry Genetics, Beijing Genomics Institute (BGI), CENTOGENE AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Inc. Illumina, Inc. , Laboratory Corporation of America Holdings, Myriad Genetics, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc.

Key Questions Answered in this Report: What are the possible long-term and short-term impacts of hereditary genetic testing on the human health continuum? What are the major market drivers, challenges, and opportunities in the hereditary genetic testing? What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market? What are the key regulatory implications in the developed and developing regions for the global hereditary genetic testing market? How are service-based companies impacting the growth of the global hereditary genetic testing industry and further shaping up future trends? How each segment of the market is expected to grow during the forecast period from 2020 to 2030? Who are the leading players with significant offerings to the global hereditary genetic testing market? What is the expected market dominance for each of these leading players? Which companies are anticipated to be highly disruptive in the future, and why? What are the needs that are yet to be met by the global hereditary genetic testing market with respect to the application area? What are the dynamics of various application areas and countries are impacting the global hereditary genetic testing market? What are the new market opportunities of various technologies influencing the growth of the global hereditary genetic testing market?

Market OverviewThe hereditary genetic testing has grown significantly since the technology was first commercialized, but it is important to quantify that growth and describe future trends.The genome testing industry is proliferating, and its growth is expected to continue at its torrid pace.

However, there are significant challenges that may dampen future growth if not addressed.

Our healthcare experts have found hereditary genetic testing to be one of the most rapidly evolving technologies, and the global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.

The unmet clinical needs for better tools to predict, diagnose, treat, and monitor disease are acting as significant factors driving the growth of sequencing industry. Other factors driving the growth include the increased understanding of the molecular basis of disease, patient demand, industry investment, and regulations that allow marketing of tests without FDA approval.

Despite rapid advanced sequencing industry growth, there are several key issues that are needed to be addressed to facilitate future growth.The relatively high total costs of delivering sequencing test results compared with other technology platforms, and limited coverage by payers, are the key challenges to the growth of this industry.

Whole genome and exome sequencing remain relatively costly requiring initial equipment investment, specialized workforce requirements, and time-intensive variant interpretation.

Within the research report, the market is segmented on the basis of oncology genetic testing, cardiology genetic testing, neurology genetic testing, product, sample, application area, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive LandscapeThe exponential rise in the application of next generation sequencing on the global level has created a buzz among companies to invest in the products and services of whole genome and exome sequencing. Due to the diverse product portfolio and intense market penetration, whole genome and exome has been a pioneer in this field and been a significant competitor in this market.

On the basis of region, North America holds the largest share, due to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. Apart from this, Latin America and the Asia-Pacific region are anticipated to grow at the fastest CAGR during the forecast period.

Countries Covered North America U.S. Canada Europe Germany France Italy U.K. Spain Russia Netherlands Rest-of-Europe Asia-Pacific China Japan India Australia Singapore Rest-of-APAC Latin America Brazil Mexico Rest-of-Latin America Rest-of-the-World (RoW)Read the full report: https://www.reportlinker.com/p05930381/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See the original post here:
Global Hereditary Genetic Testing Market: Focus on Product, Sample, Technology, Genetic Testing Type, Application Area, Country Data (16 Countries),...

A new intelligence report Pre-Pregnancy Genetic Testing Market has been recently Added into Global Market Research collection of top-line market research reports. Global Pre-Pregnancy Genetic Testing Market report is a meticulous comprehensive analysis of this market that provides access to direct first-hand insights on the growth trail of market in near term and long term. On the basis of factual advice sourced from authentic industry pros and extensive main industry research, the report provides insights about the historical growth pattern of Pre-Pregnancy Genetic Testing Market and current market situation. It then provides short- and long-term market development projections.

Projections are purely based on the detailed analysis of key Market dynamics that are expected to influence Pre-Pregnancy Genetic Testing Market performance and their intensity of impacting market growth within the span of assessment period.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-1458

In addition to evaluation of dynamics, the report provides In-depth examination of key business trends that are expected to act more prominently in global Pre-Pregnancy Genetic Testing Market. The study also provides valued information about the present and upcoming growth opportunities in Pre-Pregnancy Genetic Testing Market the important players and new market entrants can capitalize on.

Competitive companies And manufacturers in global market

Key Players

Some of the key market players for genetic testing market are Sequenom Laboratories, Illumina, Inc, Natera, Inc, Ariosa Diagnostics, Inc, BGI Health, Natera and LifeCodexx.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint.

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-1458

Opportunity assessment Provided in the Pre-Pregnancy Genetic Testing Market report Is important concerning understanding the profitable regions of investment, which are the technical insights for major market players, suppliers, vendors, and other stakeholders in Pre-Pregnancy Genetic Testing Market.

In-depth global Pre-Pregnancy Genetic Testing Market taxonomy presented in this Report offers detailed insights about each of the market sections and their sub-segments, which are categorized based on par various parameters. An exhaustive regional evaluation of global Pre-Pregnancy Genetic Testing Market divides international market landscape into essential geographies.

Regional outlook and country-wise evaluation of Pre-Pregnancy Genetic Testing Market Allows for the evaluation of multi-faceted performance of market in all the crucial markets. This advice plans to provide a wider scope of report to readers and identify the most relevant profitable areas in global market place.

Key Regions and Countries Covered in Global Pre-Pregnancy Genetic Testing Market Report-

Taxonomy and geographical analysis of the international Pre-Pregnancy Genetic Testing Market empowers readers to spot profits in present chances and catch upcoming growth opportunities even until they approach the market location. The analysis given in report is only intended to unroll the economic, societal, regulatory and political scenarios of the marketplace specific to each area and country, which might help prospective market entrants in Pre-Pregnancy Genetic Testing Market landscape to comprehend the nitty-gritty of target market regions and invent their strategies accordingly.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-1458

Major TOC Covered In this Report are:

Excerpt from:
Pre-Pregnancy Genetic Testing Expected to Witness a Fast-paced Growth Over the Forecast Period 2016 2026 Bulletin Line - Bulletin Line

WASHINGTON, July 7, 2020 /PRNewswire/ --A LUNGevity Foundation-led consortium of 41 leading patient advocacy organizations, professional societies, and industry partners has published a white paper detailing recommendations for the use of testing terminology in precision medicine for patient education throughout the cancer community. Use of consistent language will significantly improve patient awareness and understanding of potentially lifesaving testing options available for both new cancer diagnoses and progression or recurrence of disease.

Research shows that despite widespread acceptance of the importance of testing, actual testing rates lag far behind best-practice recommendations for both biomarker testing for somatic (acquired) mutations and other biomarkers, and for germline genetic testing for identifying germline (inherited) mutations (also known as variants). Analysis by The Consistent Testing Terminology Working Group (Working Group) indicates that language disparity is a primary obstacle to patient communication with providers about testing for their specific cancer type. Further, development of consistent language can increase patient understanding and communication, facilitate shared decision making, support value-based care, and assure concordance in policy development.

The Working Group is a consortium of 20 cancer patient advocacy groups representing solid tumor and hematologic malignancies, three professional societies, and 18 pharmaceutical and diagnostic companies and testing laboratories. Over the course of many years, multiple activities, led by numerous individual patient advocacy organizations and professional societies, have developed the groundwork for this effort. The Working Group has launched a multi-faceted dissemination and communications effort to ensure that its recommendations and supporting materials are widely available among all key stakeholders within the cancer ecosystem, including providers, patient advocacy organizations, guidelines agencies, payers, and policymakers.

In developing its recommendations, the Working Group, first convened in 2019 by LUNGevity Foundation, identified 33 terms related to biomarker, genetic, and genomic testing that were being used in patient education and clinical care within the different cancer communities. In many cases, multiple terms were used to describe the same test. Various testing modalities, the source of testing samples, and the multiplicity of gene mutations currently identifiable by testing were contributing factors in this often-confusing overlap.

In the final analysis, three umbrella descriptor terms emerged as recommendations from the Working Group's milestone exploration: "Biomarker testing"was selected as the preferred term for tests that identify characteristics, targetable findings, or other test results originating from malignant tissue and blood; "genetic testing for an inherited mutation" and "genetic testing for inherited cancer risk" were selected as consensus terms for tests used to identify germline (inherited) mutations.

"Far too many patients across all cancer types are still missing out on essential tests for biomarkers and inherited mutations indicating cancer risk," said Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics at Baylor Sammons Cancer Center and Staff Pathologist at Baylor University Medical Center. "With rates of biomarker testing and genetic testing for an inherited mutation at sub-optimal levels for numerous patient populations, patients are not benefiting from biomarker-directed care or not learning about their inherited cancer risk. Confusion around testing terms is a driving factor in this undertesting and ultimately has a detrimental impact on patient care."

Adds Nikki Martin, Director of Precision Medicine Initiatives at LUNGevity Foundation, "When someone is diagnosed with cancer, they're swept into a whirlwind of bewildering words and complex, pressing decisions. Our Working Group's goal is to help calm that storm of confusion with clear and consistent language that facilitates communication and medical decision-making. A unified voice and message from providers, industry, and the patient advocacy community about testing is absolutely vital to optimal cancer care."

An abstract on the Working Group's recommendations was published in May 2020 as part of the American Society of Clinical Oncology (ASCO) Annual Meeting Virtual Library.

The White Paper can be viewed in its entirety atwww.CommonCancerTestingTerminology.org.

Working Groupparticipating organizations include:

Patient Advocacy: CancerCare; Cancer Support Community;The CholangiocarcinomaFoundation;Clearity Foundation; Colorectal Cancer Alliance; Fight CRC; FORCE(Facing Our Risk of Cancer Empowered); International Cancer Advocacy Network; Leukemia & Lymphoma Society; The Life Raft Group; Lymphoma Research Foundation; Living Beyond Breast Cancer; Lung Cancer Action Network (LungCan); LUNGevity Foundation; National Lung Cancer Roundtable(American Cancer Society); PanCAN; Personalized Medicine Coalition; Prostate Cancer Foundation; Ovarian Cancer Research Alliance (OCRA); Sharsheret(The Jewish Breast & Ovarian Cancer Community);and Susan G. Komen.

Professional Societies: Association of Community Cancer Centers(ACCC);Association for Molecular Pathology(AMP); and National Society of Genetic Counselors(NSGC).

Industry Partners: Abbvie; Amgen;AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Eli Lilly and Company; Foundation Medicine; Genentech;GlaxoSmithKline (GSK); Novartis; Myriad Women's Health; NeoGenomics; Pfizer; Personal Genome Diagnostics (PGDx); andThermo Fisher Scientific.

About LUNGevity Foundation

LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, education, policy initiatives, and support and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the diseasewhile promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivorsand those who help them live better and longer lives.

Comprehensive resources include a medically vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our visiona world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization.

About Lung Cancer in the US

Please visit http://www.LUNGevity.orgto learn more.

View original content to download multimedia:http://www.prnewswire.com/news-releases/pan-cancer-consortium-moves-to-clarify-and-promote-consistent-use-of-common-terms-for-biomarker-and-germline-genetic-testing-301088874.html

SOURCE LUNGevity Foundation

Read the original post:
Pan-Cancer Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing - BioSpace

Submitted by Genetic Support Foundation

For those who have received a positive result after genetic testing for pathogenic variants that significantly increase cancer risk, a new resource is available for connecting with others who are in a similar situation.

Positive Results is a new Facebook group for support and resources around hereditary cancer risk. The group was formed by Genetic Support Foundation (GSF) to help connect the hereditary cancer community in a welcoming, digital environment. The group is administered by professionals and patients connected to GSF and aims to provide expert educational materials and to host meaningful discussions around all facets of hereditary cancer. The forum is open to those with positive results, caregivers and loved ones of those with positive results, and those in the medical community who are familiar with the unique needs of someone with hereditary cancer risk. It is not intended to replace any medical care or advice.

When patients receive a positive result for hereditary cancer risk, we often point them to external resources for support. While these resources are well-known and respected, we found that many patients want to connect with others who are going through a similar experience, explains Katie Stoll, executive director of GSF. With this new forum, we can offer people accurate information in a safe and welcoming space with support that goes beyond the counseling appointment.

Inherited pathogenic genetic variants, sometimes called mutations, play a major role in about 5 to 10 percent of all cancers. Better-known pathogenic gene variants include BRCA1 and BRCA2, which increases risk of breast and ovarian cancers, among others. But with mutations in specific genes being linked to more than 50 hereditary cancer syndromes, the hope is that all those affected will feel welcome to join the group.

Carrying the knowledge of being predisposed to cancer can be a burden, or it can be empowering, and often its both, says Nikki McCoy, who will help as an admin on the page, and who is positive for a BRCA1 gene variant. We hope that members feel empowered after visiting the group and that they feel supported and not alone. Community-building can be extremely healing and helpful.

The group is also welcoming of those who may not have had genetic testing but have a strong family history of cancer.

Women and men both have a 50 percent chance to inherit and pass down pathogenic variants. Almost all people who have a pathogenic variant will have a parent who also carries it. Many people who have a pathogenic variant and develop cancer do so at younger ages than the general population.

For more information, visit the Facebook group.

Read the original post:
Genetic Support Foundation of Olympia Announces New Resource for Hereditary Cancer Risk - ThurstonTalk

The global Direct-to-consumer Genetic Testing Marketplace gives detailed Evaluation about all of the important aspects related to the marketplace. The analysis on global Direct-to-consumer Genetic Testing market, offers profound insights about the Direct-to-consumer Genetic Testing market covering all of the crucial characteristics of the market. Moreover, the report provides historical information with prospective prediction over the forecast period. Various important aspects like market trends, revenue development patterns market shares and supply and demand are included in almost all the market research report for every single business. Some of the vital aspects analyzed in the report includes market share, production, key regions, revenue rate as well as key players.

The study of different sections of the global market are also Covered in the research report. Along with that, for the prediction periods conclusion of variables such as market size and the competitive landscape of this sector is assessed in the report. On account of the rising globalization and digitization, there are new tendencies coming to the marketplace daily. The research report provides the in-depth analysis of all of these tendencies.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2644650&source=atm

In addition, the Direct-to-consumer Genetic Testing market report also supplies the Latest tendencies in the international Direct-to-consumer Genetic Testing market with the assistance of primary as well as secondary research methods. Also, the analysis report on Direct-to-consumer Genetic Testing marketplace gives a wide evaluation of the market which includes market review, manufacturing, manufacturers, dimensions, price, value, growth rate, income, deals, export, consumption, and sales revenue of this global Direct-to-consumer Genetic Testing market. On the other hand, the Direct-to-consumer Genetic Testing market report also studies the industry standing for the prediction period. Nevertheless, this can help to increase the advertising opportunities throughout the world in addition to major market providers.

Regional and Country-level AnalysisThe report offers an exhaustive geographical analysis of the global Direct-to-consumer Genetic Testing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.Competition AnalysisIn the competitive analysis section of the report, leading as well as prominent players of the global Direct-to-consumer Genetic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Direct-to-consumer Genetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Direct-to-consumer Genetic Testing market.The following players are covered in this report:23andMeMyHeritageLabCorpMyriad GeneticsAncestry.comQuest DiagnosticsGene By GeneDNA Diagnostics CenterInvitaeIntelliGeneticsAmbry GeneticsLiving DNAEasyDNAPathway GenomicsCentrillion TechnologyXcodeColor GenomicsAnglia DNA ServicesAfrican AncestryCanadian DNA ServicesDNA Family CheckAlpha BiolaboratoriesTest Me DNA23 MofangGenetic HealthDNA Services of AmericaShuwen Health SciencesMapmygenomeFull GenomesDirect-to-consumer Genetic Testing Breakdown Data by TypeDiagnostic ScreeningPrenatal, Newborn Screening, and Pre-Implantation DiagnosisRelationship TestingDirect-to-consumer Genetic Testing Breakdown Data by ApplicationOnlineOffline

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2644650&source=atm

The Direct-to-consumer Genetic Testing market report provides helpful insights for Every established and advanced players across the world. Additionally the Direct-to-consumer Genetic Testing marketplace report provides accurate analysis for the shifting competitive dynamics. This study report includes a whole analysis of future growth concerning the evaluation of this mentioned prediction interval. The Direct-to-consumer Genetic Testing marketplace report provides a thorough study of the technological growth outlook over time to be aware of the industry growth rates. The Direct-to-consumer Genetic Testing market report also includes innovative analysis of the massive number of unique factors that are fostering or operating as well as regulating the Direct-to-consumer Genetic Testing marketplace development.

A systematized methodology can be used to create a Study on the Global Direct-to-consumer Genetic Testing Sector. For the analysis of market on the terms of research Approaches, these strategies are useful. All the Information Regarding the Products, makers, vendors, clients and even more is covered in research reports. Various important factors like market trends, earnings Growth patterns market stocks and supply and demand are contained in almost all The market research report for every single business. Adaptation of new thoughts and Accepting the latest tendencies are a few the reasons for any markets growth. The Global Direct-to-consumer Genetic Testing market research report gives the deep understanding about the Areas in which the marketplace is impactful.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2644650&licType=S&source=atm

See the article here:
Direct-to-consumer Genetic Testing Market Patents Analysis 2019-2036 - Cole of Duty

The Global Direct-to-Consumer Genetic Testing (DTC-GT) Market analysis report published on Dataintelo.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.

Get FREE Exclusive PDF Sample Copy of This Report: https://dataintelo.com/request-sample/?reportId=33062

The Global Direct-to-Consumer Genetic Testing (DTC-GT) Market report entails a comprehensive database on future market estimation based on historical data analysis. It enables the clients with quantified data for current market perusal. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and regional analysis. Listed out are key players, major collaborations, merger & acquisitions along with upcoming and trending innovation. Business policies are reviewed from the techno-commercial perspective demonstrating better results. The report contains granular information & analysis pertaining to the Global Direct-to-Consumer Genetic Testing (DTC-GT) Market size, share, growth, trends, segment and forecasts from 2020-2026.

With an all-round approach for data accumulation, the market scenarios comprise major players, cost and pricing operating in the specific geography/ies. Statistical surveying used are SWOT analysis, PESTLE analysis, predictive analysis, and real-time analytics. Graphs are clearly used to support the data format for clear understanding of facts and figures.

Customize Report and Inquiry for The Direct-to-Consumer Genetic Testing (DTC-GT) Market Report: https://dataintelo.com/enquiry-before-buying/?reportId=33062

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Primary research, interviews, news sources and information booths have made the report precise having valuable data. Secondary research techniques add more in clear and concise understanding with regards to placing of data in the report.

The report segments the Global Direct-to-Consumer Genetic Testing (DTC-GT) Market as:Global Direct-to-Consumer Genetic Testing (DTC-GT) Market Size & Share, by Regions

Global Direct-to-Consumer Genetic Testing (DTC-GT) Market Size & Share, by ProductsOver-the-Counter (OTC) ChannelOnline Channel

Global Direct-to-Consumer Genetic Testing (DTC-GT) Market Size & Share, ApplicationsAncestry-based Genetic TestsHealth and Wellness-based Genetic TestsEntertainment-based Genetic Tests

Key Players24GeneticsAncestry.com LLCDante LabsEasyDNAGenebaseAtlas BiomedFamily Tree DNAMyHeritageMapmygenome

Avail the Discount on this Report @ https://dataintelo.com/ask-for-discount/?reportId=33062

Dataintelo offers attractive discounts on customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473 | IND: +91-7000061386Email: [emailprotected]Website: https://dataintelo.com

Go here to read the rest:
Direct-to-Consumer Genetic Testing (DTC-GT) Market | Global Industry Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2026 -...

A recent Research published on the Global Preimplantation Genetic Testing marketplace provides a comprehensive comprehension of the general prospects of this marketplace. Whats more, the overview of the major findings of this study together with the megatrends affecting the increase of the Preimplantation Genetic Testing market is emphasized in the study. The market definition and introduction is included to assist our readers know the fundamental concepts of the analysis on the Preimplantation Genetic Testing industry.

According to the report, the Preimplantation Genetic Testing marketplace is set to increase the regional commerce analysis together with the major importers and exporters is contained in the research. Additionally, the supply-demand investigation as well as the crucial improvements in the Preimplantation Genetic Testing market are highlighted from the report.

Request Sample Report @ https://www.factmr.co/connectus/sample?flag=S&rep_id=292

Important Findings of this Report

Segmentation Of this Preimplantation Genetic Testing Market

Competition Tracking

The report also profiles companies operating in the preimplantation genetic testing market, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Request Methodology On This Report @ https://www.factmr.co/connectus/sample?flag=RM&rep_id=292

Important Questions Answered In this Preimplantation Genetic Testing Market Report:

Reasons To Buy This Preimplantation Genetic Testing Market Report:

Ask analyst about this report at https://www.factmr.co/connectus/sample?flag=AE&rep_id=292

Go here to read the rest:
Preimplantation Genetic Testing Market Anticipated to Grow at a Significant Pace by 2017 to 2022 - Cole of Duty

Singapore and Taiwan to be the first markets in Asia to launch the test kit

SINGAPORE, July 7, 2020 /PRNewswire/ -- Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of its Asian ancestry focused test kit, GeneLife Generations. The test kit will be officially available to customers from 20 July 2020.

From left to right: GeneLife Generations kit design and mobile application report images showcasing an ethnic mix chart and maternal migration route

Singapore and Taiwan will be the first countries in Asia to launch, followed by other markets in the coming year. GeneLife Generations has been specifically developed for the diversity and richness of the Asian ethnicities and ancestral heritage.

The GeneLife Generations Journey

Through an interactive mobile application, GeneLife Generations will bring users on a personal journey through time to discover what their DNA reveals about their ethnic mix and their lineage, providing unique experiences about possible migration routes from generations ago. This genetic composition analysis service comprehensively predicts the shared genetic composition of ancestors. Along with the genetic ancestral composition analysis, the report will identify origins and migration routes of both maternal and paternal lineages traced back to approximately 150,000 to 270,000 years ago.

Revealing Rich and Diverse Asian Ethnicities

This test kit has been specifically developed for Asian populations, unveiling the various unique ethnic origins through detailed, engaging, and rich contents. These ethnic groups include, but not limited to the following: Chinese Dai, Northern/Southern Han, Singaporean Malay, Vietnamese Kinh, Filipino, Thai, Japanese, Korean, Indonesian, Punjabi, Taiwanese, etc[1].

GeneLife Generations also covers other regions and ethnic groups from different parts of the world including Europe, Africa, and the Americas. Please note that these ethnic groups will be updated and expanded regularly as our science and research develops.

"We are truly proud to be launching GeneLife Generations amongst our suite of consumer DNA test kits," highlighted Michel Mommejat, General Manager, Genesis Healthcare Asia. "We have seen an increasing demand for Ancestry tests that truly represent the Asian population from markets that we operate in, especially Singapore. With over 16 years of R&D applied to genetics and more than 870,000 users who have taken their DNA journey with us, we are in the best position to introduce an ancestry service focused on Asia," he added.

Maternal and Paternal Ancestral Migrations

Our ancestors have travelled across the globe, looking for a place to call home in Asia. GeneLife Generations reveals migrations from maternal and paternal ancestors with an interactive display of their journeys on maps on a smartphone, supported with a dynamic chronological timeline and a range of fun and entertaining information.

The Science Behind GeneLife Generations

Genesis Healthcare is using its specially designed chip for populations in Asia and around the globe, with support from a Micro-array technology platform. For the test, DNA is simply extracted from saliva samples and subjected to genotype calling according to stringent protocols. As more users undertake the genetic test, the panel reference, algorithms, and analysis will be continuously enhanced to provide more refined information as well as reflect latest developments, technology updates and new scientific discoveries.

Story continues

Genesis Healthcare has been actively involved in genetic research and development across multiple domains and has been collaborating in joint research with the National Institute of Genetics in Japan over the years.

Availability & Price

GeneLife Generations will be launching in Singapore on 20 July 2020 at a retail price of SGD199. To celebrate this milestone, GeneLife will be running a pre-release exclusive for the first 500 customers at a discounted price of SGD129. More information can be found on http://www.genelife.asia/product_generations.

About Genesis Healthcare Co. Ltd

Genesis Healthcare Co., Ltd. is a leading biotech company, pioneering genetic research since 2004 and promoting preventive healthcare and wellness through genetic testing. Leveraging more than 16years of genetic research and development, Genesis Healthcare empowers medical institutions and end consumers alike to evolve towards personalized wellness and medicine. Over the years, more than 857,000+ users have trusted GeneLife and Genesis Healthcare to undertake genetic testing. This has allowed the company to validate and improve its science and algorithms over time. Originated in Japan, Genesis Healthcare offers medical, corporate, and consumer services through a range of innovative services across the Asia Pacific region. GeneLife is the direct-to-consumer brand of Genesis Healthcare.

Photo - https://photos.prnasia.com/prnh/20200707/2850185-1

SOURCE Genesis Healthcare Co. Ltd

Go here to read the rest:
Genesis Healthcare Co. launched 'GeneLife Generations', a New Ancestry Kit Designed for the Diversity and Richness of Asian Ethnicities and Ancestral...

A Henrico County-based laboratory company said Tuesday that it is planning to hire about 400 employees as it ramps up its testing capability for the virus that causes COVID-19.

Genetworx, a molecular diagnostic testing lab, said it has immediate hiring needs for jobs such as data entry, lab technicians, tech assistants, project managers, business managers, hiring managers and other work at its facility in the Innsbrook Corporate Center in western Henrico.

We are working 24 hours a day, said Brian ONeill, the companys founder. We have all the equipment to do 100,000 tests a day, and we have the customers. The United States is experiencing a massive demand for COVID-19 testing. We are running three shifts, flat out, and we need to hire at least another 400 people in the next several weeks.

Genetworx now employs about 350 people in the Richmond area, ONeill said. The company also has a laboratory near Philadelphia that is hiring.

It opened its Henrico laboratory in 2013 to do molecular testing for cancer, respiratory illness, genetic testing and other lab work.

With the coronavirus pandemic, the company started offering COVID-19 tests.

We were very busy before this, but we are extremely busy now, he said.

ONeill said jobs would pay between $40,000 and $100,000 a year.

We are willing to train smart people that want to come work for us, he said. We have a program called Re-employing America, and we are targeting people whose jobs were affected by the pandemic, and others. We are also hiring people from the laboratory industry and the health care industry as other labs have seen their work decrease because of less visits to health care.

Genetworx initially leased space in the former Innsbrook Library branch in 2013. Last month, the company leased 19,335 square feet of office space at the Park III building at 4144 Innslake Drive.

ONeill said it now has about 80,000 square feet of space in the two buildings.

See the original post here:
Henrico laboratory hiring 400 as it ramps up COVID-19 testing - Richmond.com

BANGALORE, July 8, 2020 /PRNewswire/ -- Eurofins Clinical Genetics is accredited by NABL & approved by ICMR to perform COVID-19 RT-PCR based testing (ViroSure-19). Eurofins new facility in Peenya, Bangalore is dedicated to Virology testing. Eurofins India has taken steps to support community by starting COVID-19 testing.

The ViroSure-19 test helps clinicians to detect the presence of COVID-19 in human respiratory samples. This diagnostic test offers fast detection of infection and facilitates emergency medical aid to patients before it is too late. Coming from a multinational brand, known for its accuracy and reliability in clinical diagnostics, ViroSure-19 is a sure bet in COVID-19 diagnosis. Today, COVID-19 test is ray of hope to millions of people across the globe and an effective solution like ViroSure-19 becomes a powerful armor to defeat the virus spread.

According to the Eurofins Clinical Genetics BU Head, Mr. Sudhanshu Srivastava,"Eurofins laboratories are fully operational to support patients & families through COVID testing & counseling".The ViroSure-19 is real-time multiplex PCR to detect SARS-CoV-2 in the most efficient way possible. Within a quarter, the team worked rigorously with specialists across organizations team of scientists on building the right test and contributing scientific excellence in infectious disease testing.

Eurofins, has been a very established company with regard to testing services for over 35 years. Eurofins India is now well-prepared to deliver COVID-19 testing across the country. Always recognized for the reliability and accuracy indexes of their products, ViroSure-19has been thoroughly examined by the Eurofins R&D team. As accredited by NABL and approved by ICMR, the ViroSure-19 provided precise results throughout the final testing period. Dr. Sam Balu, Asst. Lab Director, Eurofins Clinical Genetics, said, "I amexpecting a break in the cloud amidst this pandemic situation and hoping for ViroSure-19 diagnosis to help save lives." It will hence help reduce the risk of community spread of the virus amongst Indian metropolitan cities, detect COVID-19 positive cases precisely, and contribute to the fight, the world is pursuing against the global pandemic. Eurofins Clinical Genetics services based on NGS including Exome testing & prenatal testing remain functional throughout lockdown period to serve patients. Eurofins Clinical Genetics has also developed SARS-CoV-2 genome sequencing studies supporting various research organizations to develop preventive strategies against novel corona virus.

About Eurofins

Pioneering in food, environment, pharmaceutical, clinical diagnostics, cosmetic products testing solutions and genetic testing Eurofins remains the global leader with its superior industry standards in quality, accuracy, affordability, and global presence. The number of testing facilities has reached as large as 800 in 50 countries and fast expanding to many more locations. Started as Eurofins Scientific in 1987, the company started to grow with a mission of contributing to a safer and healthier world and never looked back after 2002. Due to unprecedented times, the company's objectives have been directed towards drawing scientific experience to develop a range of SARS-CoV-2 tests in response to the Coronavirus pandemic. To know more about COVID-19 testing at Eurofins India, please connect via mail at salesecgi@eurofins.com or give them a callat +91-95135-20807/ +91-806722-3200.

For details, please visit: https://www.eurofinsclinicalgenetics.co.in/

Media Contact:Eurofins Indiasalesecgi@eurofins.com+91-95135-20807Eurofins Clinical Genetics India Pvt. Ltd.

More here:
Eurofins, the World Leader in Bio-analytical Testing, Launches ViroSure-19, One of the Most Accurat - PharmiWeb.com

Orphan Drug Designation granted to Neurogenes adeno-associated virus vector with engineered transgene encoding the human CLN5 gene

Neurogene Inc., a company founded with a mission to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to adeno-associated virus vector with engineered transgene encoding the human CLN5 gene for patients with CLN5, a form of Batten disease. Batten disease, a common name for a rare class of diseases called neuronal ceroid lipofuscinoses (NCL), affects an estimated 2-4 out of every 100,000 children in the United States.

"CLN5 is a devastating neurodegenerative disease with no FDA approved treatment options," said Rachel McMinn, Ph.D., Neurogenes Founder and Chief Executive Officer. "Receiving Orphan Drug Designation from the FDA is an important regulatory milestone, and we look forward to advancing our gene therapy program into the clinic."

The FDA grants Orphan Drug Designation to drugs and biologics intended for the safe and effective treatment, diagnosis or prevention of rare diseases or conditions affecting fewer than 200,000 people in the United States. Orphan Drug Designation provides benefits to drug developers designed to support the development of drugs and biologics for small patient populations with unmet medical needs. These benefits include assistance in the drug development process, tax credits for clinical costs, exemptions from certain FDA fees and seven years of marketing exclusivity.

About CLN5Batten disease, also called neuronal ceroid lipofuscinoses (NCLs), is a family of rare and fatal neurodegenerative diseases caused by pathogenic changes in one of a series of genes that result in the accumulation of abnormal storage material across multiple organ systems, including the brain, eye, skin and other tissues. The most prominent effects occur in the brain, where the progressive and inevitable loss of neurons lead to devastating declines in cognitive and motor function in those with Batten disease. The subtype CLN5 is a rare, pediatric-onset and rapidly progressive disease caused by defects in the CLN5 gene. CLN5 disease is characterized by progressive deterioration in intellectual and motor capabilities and vision loss, as well as seizures and death in childhood or adolescence. Diagnosis of the disease is confirmed through genetic testing. Currently, there are no approved disease-modifying therapies available.

About Genetic TestingNeurogene is committed to lowering the barriers of obtaining a genetic diagnosis for patients and has partnered with Invitae to co-sponsor two genetic testing programs. Healthcare providers can order, at no charge, an Invitae Epilepsy panel for any child under the age of eight who has had an unprovoked seizure, or the Detect Lysosomal Storage Diseases panel for patients suspected of having a lysosomal storage disease. Visit https://www.invitae.com/en/sponsored-testing/ for more details.

About Neurogene Inc.Neurogene Inc. is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring therapies to patients that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs are designed to use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy. For more information, visit http://www.neurogene.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005106/en/

Contacts

Nikki Kiddnikki.kidd@rturnmktg.com 773-257-7523

Originally posted here:
FDA Grants Orphan Drug Designation to Neurogenes Gene Therapy for the Treatment of CLN5 Batten Disease - Yahoo Finance

Global Point-Of-Care Genetic Testing market study presents an in-depth scenario which is segmented according to manufacturers, product type, applications, and regions. This segmentation will provide deep-dive analysis of the Point-Of-Care Genetic Testing industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on past and present Point-Of-Care Genetic Testing industry situations and growth aspects. All the key regions covered in Point-Of-Care Genetic Testing report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Point-Of-Care Genetic Testing market share and market outlook of each region from 2020-2027 are presented in this report. A deep study of Point-Of-Care Genetic Testing market dynamics will help the market aspirants in identifying the business opportunities which will lead to accumulation of revenue. This segment can effectively determine the Point-Of-Care Genetic Testing risk and key market driving forces.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-3138

Initially, the report presents the Point-Of-Care Genetic Testing market overview covering product description, market analysis, market dynamics, opportunities and market share. Secondly, global report conducts a qualitative analysis to present the key manufacturers profile, Point-Of-Care Genetic Testing market share, market size, sales volume, gross margin analysis.

The Point-Of-Care Genetic Testing report is segmented to provide a clear and precise view of the global Point-Of-Care Genetic Testing market statistics and market estimates. Point-Of-Care Genetic Testing report Data represented in the form of graphs, charts, and figures will show the Point-Of-Care Genetic Testing growth rate, volume, target consumer analysis. This report presents the crucial data to all Point-Of-Care Genetic Testing industry aspirants which will facilitate useful business decisions.

Key Players

Cepheid, IQuum, Biocartis, Abbott, Idaho Technologies, ThermoFisher, Roche, Optigene, Lumora are some of the global key players in point-of-care genetic testing. In 2016, Biocartis Idyllas distribution rights were also granted to Thermofisher in the US. The Idylla platform is a fully integrated system enabling laboratories to perform a broad range of applications in oncology and beyond. But in 2014, Iquums Liat Analyzers rights were acquired by Roche Molecular Diagnostics.

The report covers exhaustive analysis on:

The regionalanalysis includes:

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-3138

The Point-Of-Care Genetic Testing report cover following data points:

Part 1: This part enlists the global Point-Of-Care Genetic Testing market overview, covering the basic market introduction, market analysis by type, applications, and regions. The major Point-Of-Care Genetic Testing producing regions include North America, Europe, Asia-Pacific, Middle-East, and Africa. Point-Of-Care Genetic Testing industry states and outlook (2020-2027) is presented in this part. In addition, Point-Of-Care Genetic Testing market dynamics stating the opportunities, market risk, and key driving forces are studied.

Part 2: This part covers Point-Of-Care Genetic Testing manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Point-Of-Care Genetic Testing product price, gross margin analysis, and Point-Of-Care Genetic Testing market share of each player is profiled in this report.

Part 3 and Part 4: This part presents the Point-Of-Care Genetic Testing competition based on sales, revenue, and market share of each manufacturer. Part 4 covers the Point-Of-Care Genetic Testing market scenario based on regions. Region-wise Point-Of-Care Genetic Testing sales and growth (2015-2019) is studied in this report.

Part 5 and Part 6: These two sections cover the North America and Europes Point-Of-Care Genetic Testing industry by countries. Under this the Point-Of-Care Genetic Testing revenue, market share of the countries like USA, Canada, and Mexico is provided. Under Europe Point-Of-Care Genetic Testing report includes, the countries like Germany, UK, France, Russia, Italy, Russia and their sales and growth is covered.

Part 7, Part 8 and Part 9: These 3 sections covers Point-Of-Care Genetic Testing sales revenue and growth for the regions like Asia-Pacific, South America, Middle East & Africa. Under these regions Point-Of-Care Genetic Testing report covered, the countries like China, Japan, Korea, India, Brazil, Columbia, Argentina, Egypt, Saudi Arabia, Nigeria and South Africa. The sales and growth in these regions are presented in this Point-Of-Care Genetic Testing industry report.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-3138

Part 10 and Part 11: This part depicts the Point-Of-Care Genetic Testing market share, revenue, sales by product type and application. The Point-Of-Care Genetic Testing sales growth seen during 2012-2020 is covered in this report.

Part 12 and Part 13: This part provides forecast information related to Point-Of-Care Genetic Testing market (2020-2027) for each region. The sales channels including direct and indirect Point-Of-Care Genetic Testing marketing, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These parts present Point-Of-Care Genetic Testing market key research findings and conclusion, research methodology, and data sources are covered.

Thus, Global Point-Of-Care Genetic Testing report is a complete blend covering all the vital market aspects.

More:
Soaring Demand for Clean-label Food Products to Trigger the Growth of the Point-Of-Care Genetic Testing Market 2017-2027 - Cole of Duty